Methods
The GSH nursery is a 75-bed tertiary unit that admits in excess of 2 000 infants per year, over 500 of whom have a birth weight of less than 1 500 g.
Data were retrospectively collected on all infants who received red blood cell transfusions in the GSH nursery over a 6-month period in 2011 after adoption of a restrictive BTF policy. Data were collected from the blood bank and the patients' medical records and included gestational age, number of BTFs per infant, timing of BTF, clinical status and policy adherence. BTF figures for a similar 6-month period in 2008 before the restrictive policy were obtained for comparison.
Data were analysed with Stata software version 12 (Statacorp, College Station, Tex., USA). Proportions were compared using the chi-square test. Statistical significance was set at p<0.05.
Ethical approval for the study was obtained from the University of Cape Town Faculty of Health Sciences Human Research Ethics Committee.
Results
The restrictive protocol was adhered to in 100% of cases in which infants received BTFs during the study period. After introduction of the restrictive policy, 42 (3.8%) of a total of 1 097 infants admitted received a total of 64 BTFs. Of the transfusions 70% were to babies with a birth weight of <1 500 g, with most transfusions (39%) being performed between 14 and 28 days after birth. Apart from one baby who developed necrotising enterocolitis after transfusion, no adverse events were recorded.
In comparison, 102 (10.9%) of a total of 940 infants admitted during a period of the same length before introduction of the restrictive policy received a total of 121 BTFs (Fig. 2) .
Comparison between total BTFs administered in 2008 and in 2011 showed a highly statistically significant difference (p<0.001). Background. Blood transfusions (BTFs) are not without risk and pose a significant financial burden on resource-limited services. In line with current international evidence, the nursery at Groote Schuur Hospital (GSH), Cape Town, South Africa, introduced a restrictive BTF protocol to minimise transfusions and manage costs. Objective. To determine whether adopting a restrictive BTF policy results in fewer transfusions. Methods. Data were retrospectively collected on all infants who received BTFs in the GSH nursery over a 6-month period following adoption of a restrictive BTF policy in 2010. BTF figures for a similar time period before the restrictive policy, during 2008, were obtained for comparison. Results. After introduction of the restrictive BTF policy, 42 of 1 097 infants admitted (3.8%) received a total of 64 BTFs. In comparison, 102 of a total of 940 infants (10.9%) admitted during a period of the same length before introduction of the restrictive BTF policy received a total of 121 transfusions. Comparison between the number of BTFs administered before and after the restrictive policy showed a highly statistically significant difference (p<0.001). The total cost of the blood products used in the two 6-month periods was R91 870 v. R48 640, based on current prices. Conclusions. By adopting a restrictive policy, we were able to halve the number of BTFs, reduce risks associated with transfusions, and achieve significant cost benefits. Following evidence-based guidelines results in high standards of care, while also making the most effective use of resources.
Resource implications of adopting a restrictive neonatal blood transfusion policy
The cost of the blood products used in the 6 months of 2011 was R48 640 compared with R91 870 in 2008, based on current prices (Table 1 ).
Discussion
Before introduction of the restrictive BTF policy in the GSH nursery the unit did not have a standardised restrictive protocol to inform BTF decisions, which were left to the discretion of the individual attending doctors. These decisions were often made on an empiric basis, and variations in practice existed between individuals.
In a recent Cochrane review, four trials that enrolled a total of 614 infants compared low (restrictive) with high (liberal) haemoglobin thresholds. There were no statistically significant differences in the combined outcomes of death or serious morbidity at first hospital discharge. [5] This review, coupled with our drive to adopt cost-effective evidence-based guidelines in our unit, resulted in the introduction of a restrictive BTF policy. The adoption of this protocol was consensus driven and had unanimous 'buy in' from all senior clinicians in the unit. The 'buy-in' was evidenced by the fact that the new protocol achieved 100% compliance during the entire study period.
Evidence-based medicine has been described as 'the conscientious, explicit and judicious use of current best evidence in making decisions about the care of individual patients' . [6] Implementation of evidence-based protocols facilitates translation of clinical trials into day-to-day practice, with maintenance of the highest quality and safety of care. Furthermore, resources are allocated cost-effectively.
During the two time periods studied, while the number of admissions remained similar, the number of BTFs administered was almost halved. What was more marked was that the number of infants receiving BTFs was reduced from 102 to 42, representing an almost 60% reduction. This resulted in marked cost savings and preservation of scarce blood products, while also decreasing patient exposure to potentially harmful side-effects.
Conclusions
We have demonstrated that it is possible to achieve 100% compliance with the commitment of the entire healthcare team, while standardising neonatal care. We were able to halve the number of BTFs and achieve significant cost benefits. Following evidence-based guidelines ensures high standards of care while also making the most effective use of resources. 
